Type 2 asthma paediatric patients eligible for dupilumab: An Italian biomarker-based analysis by Giorgio Piacentini, MD, Alessandro Fiocchi, MD, Gianluigi Marseglia, MD, Michele Miraglia Del Giudice, MD, Renato Cutrera, MD, Rossella Bitonti, MSc, Francesca Fanelli, MSc, Annalisa Stassaldi, MSc, Giuliana Nicolosi, MD, Gianluca Furneri, MSc

Get full text